July 7th, 2023
12:00 PM Pacific
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about AMO Pharma.
During this session AMO Pharma will give the first presentation of their recently completed pivotal study of AMO-02 in the treatment of myotonic dystrophy. Click here to read more!
More information coming soon!